MY173864A - Site-directed modification of fviii - Google Patents

Site-directed modification of fviii

Info

Publication number
MY173864A
MY173864A MYPI2013000709A MYPI2013000709A MY173864A MY 173864 A MY173864 A MY 173864A MY PI2013000709 A MYPI2013000709 A MY PI2013000709A MY PI2013000709 A MYPI2013000709 A MY PI2013000709A MY 173864 A MY173864 A MY 173864A
Authority
MY
Malaysia
Prior art keywords
site
fviii
directed modification
polyethylene glycol
covalently bound
Prior art date
Application number
MYPI2013000709A
Inventor
Clark Q Pan
John E Murphy
Baisong Mei
Jonathan S Strauss
Jianmin Chen
Thomas Barnett
Hendri Tjandra
Liang Tang
Deqian Wang
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Priority to MYPI2013000709A priority Critical patent/MY173864A/en
Publication of MY173864A publication Critical patent/MY173864A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain VIII procoagulant activity and have improved pharmacokinetic properties.
MYPI2013000709A 2007-05-18 2007-05-18 Site-directed modification of fviii MY173864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Publications (1)

Publication Number Publication Date
MY173864A true MY173864A (en) 2020-02-25

Family

ID=79170498

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Country Status (1)

Country Link
MY (1) MY173864A (en)

Similar Documents

Publication Publication Date Title
PH12019501613A1 (en) Site-directed modification of fviii
EP3406347A3 (en) Xten conjugate compositions and methods of making same
MX2008001706A (en) Conjugates of a g-csf moiety and a polymer.
MX2009007145A (en) Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage.
WO2006047419A3 (en) Heterobifunctional poly(ethylene glycol) and uses thereof
GB201009493D0 (en) Modified recombinant factor viii and von willebrand factor and methods of use
GB2492935A (en) Conjugated blood coagulation factor VIII
DE502008001256D1 (en) CATIONIC CONDITIONING AGENT
MX2010001955A (en) Polymeric linkers containing pyridyl disulfide moieties.
EP2309989A4 (en) PHARMACOLOGICALLY CHARGED POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME
GEP20156230B (en) Forms of rifaximin and usage thereof
DE602007012072D1 (en) ORANTAGONISTEN
EP2151461A3 (en) Benzylated polyalkylene polyamines and uses thereof
DK1799748T3 (en) Biodegradable cationic polymers
ATE475667T1 (en) TEMPLATE-FIXED PEPTIDOMIMETICS
EP1663171A4 (en) Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions
CY1116415T1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING L-733060 FOR USE IN THE TREATMENT OF CANCER TREATMENT
MX2010004899A (en) Novel neurturin conjugates for pharmaceutical use.
MY151329A (en) Site-directed modification of fviii
MY173864A (en) Site-directed modification of fviii
MY181129A (en) Site-directed modification of fviii
CY1125477T1 (en) SITE-DIRECTED MODIFICATION OF FVIII
SV2007002756A (en) MODIFICATION DIRECTED TO THE FVIII SITE
MY156568A (en) Peptide-polymer conjugates
GT200700040A (en) MODIFICATION DIRECTED TO THE FVIII SITE